购物车
- 全部删除
- 您的购物车当前为空
GNE-502 is an orally active and potent estrogen receptor (ER) degrader, specifically designed for research on breast cancer.
GNE-502 is an orally active and potent estrogen receptor (ER) degrader, specifically designed for research on breast cancer.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 6,250 | 期货 |
产品描述 | GNE-502 is an orally active and potent estrogen receptor (ER) degrader, specifically designed for research on breast cancer. |
体内活性 | GNE-502 (10 and 100 mg/kg; p.o.) possesses sufficient oral exposure to be tested in a WT MCF7 tumor xenograft model[1]. .. GNE-502 shows dose dependent tumor growth inhibition at 10 mg/kg and 30 mg/kg, with tumor stasis at 100 mg/kg[1]. Animal Model: Mouse[1]Dosage: 10 and 100 mg/kg (Pharmacokinetic Analysis) Administration: P.o. Result: Possessed sufficient oral exposure to be tested in a WT MCF7 tumor xenograft model. |
分子量 | 471.59 |
分子式 | C25H30FN3O3S |
CAS No. | 1953134-16-1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容